PT-141 10mg
PT-141 is a synthetic cyclic heptapeptide assigned CAS number 189691-06-3, with the structural framework Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. It is a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) developed through systematic structure-activity research on the melanocortin receptor pharmacophore. The defining feature is a lactam bridge between the side chains of Asp and Lys, which constrains the central His-D-Phe-Arg-Trp message sequence into a binding-competent conformation. As a research-grade synthetic peptide, PT-141 is used as a reference compound in melanocortin receptor binding assays, in cyclic-peptide synthesis methodology research, and in structure-activity studies of the alpha-MSH pharmacophore. PT-141 was developed in the late 1990s by Palatin Technologies as part of structure-activity work on cyclic analogs of alpha-MSH. The compound entered the chemical literature under the development code PT-141 and the INN bremelanotide. It has since become a reference standard in cyclic-peptide methodology and in melanocortin receptor pharmacology research. Full analytical specifications - including molecular formula, molecular weight, and HPLC-UV purity - will be published on this page following independent third-party Certificate of Analysis verification. Current status: COA testing in progress. ITide Labs supplies PT-141 as a reference compound for laboratory research conducted by qualified professionals only.
$50.00
PT-141 is a synthetic cyclic heptapeptide assigned CAS number 189691-06-3, with the structural framework Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH.
Need a larger quantity? Contact us for custom bulk pricing.
Volume Discounts
Researcher Account Required
Create a free researcher account to place orders.
ITide+ Laboratories sells exclusively to verified researchers. All products are Research Use Only (RUO) — for laboratory research use only, diagnostic use, or therapeutic application.
By creating an account you confirm you are a qualified researcher and will use these compounds in accordance with all applicable laws and regulations.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.
- ✓ Lyophilized powder, research grade
- ✓ For laboratory research use by qualified professionals
COA Coming Soon
Third-party lab analysis for this lot is in progress. The Certificate of Analysis will be published upon completion.
PT-141 is a synthetic cyclic heptapeptide assigned CAS number 189691-06-3, with the structural framework Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH. It is a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) developed through systematic structure-activity research on the melanocortin receptor pharmacophore. The defining feature is a lactam bridge between the side chains of Asp and Lys, which constrains the central His-D-Phe-Arg-Trp message sequence into a binding-competent conformation. As a research-grade synthetic peptide, PT-141 is used as a reference compound in melanocortin receptor binding assays, in cyclic-peptide synthesis methodology research, and in structure-activity studies of the alpha-MSH pharmacophore.
PT-141 was developed in the late 1990s by Palatin Technologies as part of structure-activity work on cyclic analogs of alpha-MSH. The compound entered the chemical literature under the development code PT-141 and the INN bremelanotide. It has since become a reference standard in cyclic-peptide methodology and in melanocortin receptor pharmacology research.
Full analytical specifications - including molecular formula, molecular weight, and HPLC-UV purity - will be published on this page following independent third-party Certificate of Analysis verification. Current status: COA testing in progress.
ITide Labs supplies PT-141 as a reference compound for laboratory research conducted by qualified professionals only.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.
For laboratory research purposes only by qualified professionals. This product has not been evaluated by the FDA for clinical application.